Skip to content
bioinnovationbeacon.com

bioinnovationbeacon.com

  • Home
  • AI
  • Biotech News
  • Research
  • Technology
  • Press Releases
  • Privacy Policy
  • Contact Us

Transactions under Novonesis’ share buyback program

November 2, 2026byadmin
transactions-under-novonesis’-share-buyback-program

Please read the announcement in PDF

Attachment

  • 2026_26_Share_buyback

Globenewswire

Post navigation

Tiziana touts multiple sclerosis win at lower dose as high dose misses mark
Sun Pharma stops eye-care drug production at Indian plant amid quality issues

Related Posts

arraypatch-memuktamadkan-pusingan-pembiayaan-benih-e3.2-juta-yang-menerima-lebihan-langganan-untuk-memajukan-terapeutik-mikroneedle-generasi-seterusnya
ArrayPatch Memuktamadkan Pusingan Pembiayaan Benih €3.2 Juta yang Menerima Lebihan Langganan untuk Memajukan Terapeutik Mikroneedle Generasi Seterusnya

CORK, Ireland, Nov. 05, 2026 (GLOBE NEWSWIRE) — ArrayPatch Ltd (“ArrayPatch”), sebuah syarikat bioteknologi yang membangunkan terapeutik inovatif berasaskan mikroneedle,…

marvel-announces-final-shank3-data:-mb-204-highly-effective-at-reversing-autism-behaviours
Marvel Announces Final Shank3 Data: MB-204 Highly Effective at Reversing Autism Behaviours

CALGARY, Alberta, Nov. 10, 2026 (GLOBE NEWSWIRE) — Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF), and its wholly-owned subsidiary,…

kamada-to-announce-third-quarter-and-nine-months-ended-september-30,-2026,-financial-results-on-november-9,-2026
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2026, Financial Results on November 9, 2026

Company to Host Conference Call at 8:30am ET REHOVOT, Israel and HOBOKEN, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) — Kamada…

| Depth News by Ascendoor | Powered by WordPress.